Cargando…
Repurposing Statin Drugs to Decrease Toxicity and Improve Survival Outcomes in Head and Neck Cancer
OBJECTIVE: The rising incidence of head and neck squamous cell carcinoma (HNSCC) calls for the assessment and improvement of currently available therapies that may enhance the therapeutic ratio in these patients. Statin drugs are one of the most widely used drug classes in the world for their lipid-...
Autores principales: | Bourguillon, Richard O., Stokes, William A., Dorth, Jennifer, Schmitt, Nicole C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669126/ https://www.ncbi.nlm.nih.gov/pubmed/34917872 http://dx.doi.org/10.1177/2473974X211065715 |
Ejemplares similares
-
Malignant Fungating Wounds of the Head and Neck: Management and Antibiotic Stewardship
por: O’Neill, Liam, et al.
Publicado: (2022) -
Molecular mechanisms of statin intolerance
por: Gluba-Brzozka, Anna, et al.
Publicado: (2016) -
The role of statins in lung cancer
por: Amin, Fatemeh, et al.
Publicado: (2021) -
Toxicity of Chimeric Antigen Receptor T Cells and its Management
por: Wudhikarn, Kitsada, et al.
Publicado: (2021) -
Psychiatric manifestations of neurologic disease: where are we headed?
por: Lyketsos, Constantin G., et al.
Publicado: (2007)